Clinical Trials Logo

Filter by:
NCT ID: NCT06199999 Recruiting - Pain, Postoperative Clinical Trials

Erector Spinae Plane Block vs Local Infiltration Following Fusion Surgery

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

The proposed intervention will examine two alternative methods for postoperative pain control. Two treatment arms of this study will include subjects who receive an erector spinae block (ESP) after induction of anesthesia but prior to the start of surgery and subjects who will receive a high volume of local anesthetic infiltration at the end of the procedure before emergence from anesthesia. The control group of subjects will undergo spinal surgery with general anesthesia but without any regional anesthesia. Outcome measurements include evaluation of serum inflammatory markers, pain scores, opioid usage and standardized evidence-based assessment methodologies.

NCT ID: NCT06199986 Recruiting - Prostate Cancer Clinical Trials

DeADT - Living Well With Prostate Cancer

DeADT-LW
Start date: October 4, 2022
Phase: N/A
Study type: Interventional

The goal of this pilot randomized implementation trial is to compare two strategies to reduce low-value androgen deprivation therapy (ADT) use for prostate cancer care. The aim of the study is to compare implementation of the two strategies: use of a clinical reminder order check intervention versus a provider script/patient education approach, and their impacts on low-value ADT use after six months. The main goal of both interventions will be to decrease ADT overuse for patients with prostate cancer, but to do this in a way that is acceptable to the clinicians who treat these patients. Provider participants will engage with one of the interventions triggered in the electronic health record when their patients are deemed likely to be receiving low-value ADT. Provider participants receive only one intervention. The intervention is triggered for every clinic visit involving a patient deemed to be receiving low-value ADT, so provider participants may receive their assigned intervention multiple times. Researchers will compare provider use of both strategies to determine implementation outcomes and whether one was more effective in reducing low-value ADT use.

NCT ID: NCT06199934 Active, not recruiting - SARS-CoV-2 Clinical Trials

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Start date: February 7, 2024
Phase:
Study type: Observational

The primary purpose of this study is to learn about how well different versions of the Pfizer-BioNTech COVID-19 vaccine (called BNT162b2) work at preventing death, severe COVID-19 that requires a trip to the hospital, and overall use of healthcare resources, such as needing to go the doctor or urgent care due to illness. Pfizer is not enrolling any participants for this study. Instead, existing data from different health data sources will be used to help answer the scientific questions Pfizer is interested in learning more about.

NCT ID: NCT06199726 Recruiting - Clinical trials for Reproductive Behavior

REFLECT: Reproductive Education and Fertility Links for Cancer Treatment

REFLECT
Start date: December 11, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate a web-based education tool geared at helping Adolescent and Young Adult (AYA) patients better understand fertility and genetic risks for cancer in future offspring.

NCT ID: NCT06199713 Recruiting - Melanoma Clinical Trials

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Start date: January 30, 2024
Phase:
Study type: Observational

The purpose of this research study is to determine if analysis of PET/CT scans and testing of blood samples in people with melanoma that has spread in their body can help researchers determine which patients are more or less likely to respond to immunotherapy and are more or less likely to have side effects. 24 participants will be enrolled and be on study until approximately 4 weeks after their first dose of Immune Checkpoint Inhibitor therapy.

NCT ID: NCT06199661 Completed - Functional Fitness Clinical Trials

High-Intensity Exercise in Older Adults

Start date: March 6, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study was to test the high-intensity interval training called Aphasia Physical Exercise (APEX) in healthy older adults. The main questions it aimed to answer were: 1. what is the safety and feasibility of APEX? 2. what are APEX's acute physiological effects? 3. what is APEX's effects on functional fitness? 4. what is APEX's effects on cognition? Participants underwent: - Baseline testing session (#1) with cognitive measures only (a week before the Pre-exercise session); - Pre-exercise session (#2) with maximum oxygen consumption and heart rate assessment, functional fitness and cognitive measures (3-7 days before the start of the exercise program); - APEX program, two APEX classes per week for four weeks (eight classes in total); - Post-exercise session (#3), functional fitness and cognitive measures, (0-2 days after the end of the exercise program).

NCT ID: NCT06199570 Recruiting - Lung Cancer Clinical Trials

Support for Cancer Patients Awaiting News

SCAN
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the intervention and/or protocol prior to a Pilot Randomized Controlled Trial phase. The Open Trial phase is an unblinded, single-site, single-arm open trial (n=10). The Pilot randomized clinical trial (RCT) phase is an unblinded, single-site, feasibility pilot randomized controlled trial (n=50).

NCT ID: NCT06199531 Recruiting - NGLY1 Deficiency Clinical Trials

Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency

Start date: February 13, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

A non-randomized, open-label, dose escalation study of a single intracerebroventricular (ICV) administration of a gene replacement therapy in subjects who are 2 to 18 years old with NGLY1 Deficiency.

NCT ID: NCT06199492 Not yet recruiting - Needle Biopsy Clinical Trials

Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures

Start date: June 30, 2024
Phase: N/A
Study type: Interventional

To learn if an investigational imaging device can help to identify tumor tissue before a biopsy is taken.

NCT ID: NCT06199479 Recruiting - Pseudoprogression Clinical Trials

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Start date: June 4, 2024
Phase: Phase 1
Study type: Interventional

To learn if advanced imaging methods can tell apart true progression (the disease has actually gotten worse) from pseudoprogression (the disease appears to have gotten worse, but it actually has not).